143 related articles for article (PubMed ID: 6814410)
1. Immunological types of lymphoproliferative disorders in a cohort: a 4-year study.
Lowenthal RM; Sawyer PJ; Lickiss JN; Harlow RW; Kirov SM; Woods GM
Aust N Z J Med; 1982 Aug; 12(4):258-62. PubMed ID: 6814410
[TBL] [Abstract][Full Text] [Related]
2. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
3. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
5. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. I. Acute lymphocytic leukaemia (ALL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):187-95. PubMed ID: 6326553
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte surface markers in lymphoproliferative disorders.
Aiuti F; Lacava V; Fiorilli M; Ciarla MV
Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
[No Abstract] [Full Text] [Related]
7. [T-and B-lymphocytes in lymphoproliferative syndromes].
Girard JP; Fernandes B
Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
[TBL] [Abstract][Full Text] [Related]
8. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
Gupta S; Good RA
Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
[No Abstract] [Full Text] [Related]
9. Immunoglobulin abnormalities in malignant non-Hodgkin's lymphoma.
Economidou J; Terzoglou K; Anagnostou D; Nikiforakis EM; Papajannis A
Scand J Haematol; 1984 Aug; 33(2):123-8. PubMed ID: 6433436
[TBL] [Abstract][Full Text] [Related]
10. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
Tanaka E
Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
[No Abstract] [Full Text] [Related]
11. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
12. Combined T and B lymphocyte marker test in lymphoproliferative disorders.
Chapel HM; Ling NR
Br J Haematol; 1977 Mar; 35(3):367-71. PubMed ID: 403927
[TBL] [Abstract][Full Text] [Related]
13. A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders.
Polliack A; Siegal FP; Clarkson BD; Fu SM; Winchester RJ; Lampen N; Siegal M; De Harven E
Scand J Haematol; 1975 Dec; 15(5):359-76. PubMed ID: 812174
[TBL] [Abstract][Full Text] [Related]
14. Membrane phenotypic studies in B cell lymphoproliferative disorders.
Scott CS; Limbert HJ; MacKarill ID; Roberts BE
J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
[TBL] [Abstract][Full Text] [Related]
15. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma.
Cader A; Richardson P; Walsh L; Ling NR; MacLennan IC; Jones EL; Leyland M
Br J Cancer; 1983 Aug; 48(2):185-93. PubMed ID: 6603860
[TBL] [Abstract][Full Text] [Related]
16. [Immunological aspects of malignant lymphoproliferative diseases].
Rivero I; Diumenjo M
Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
[No Abstract] [Full Text] [Related]
17. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
18. Chronic lymphocytic leukaemia and its relationship to other lymphoproliferative disorders.
Sweet DL; Golomb HM; Ultmann JE
Clin Haematol; 1977 Feb; 6(1):141-57. PubMed ID: 334406
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal immunoproliferative disorder of B-lymphocytes IgD/lambda changing from chronic lymphocytic leukaemia to myeloma and plasmacytic leukaemia pattern.
Buchi G; Palestro G; Leonardo E; Termine G; Autino R
Acta Haematol; 1982; 68(2):105-8. PubMed ID: 6812364
[TBL] [Abstract][Full Text] [Related]
20. Surface marker studies in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
Leong AS; Forbes IJ; Cowled PA; Sage RE; Black RB; Dale B; Zalewski PD
Pathology; 1979 Jul; 11(3):461-71. PubMed ID: 392424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
